BCL2L1 and neoplasm: Dysregulated proliferation is a significant hallmark of tumor cells [19], and the regulatory factors include antiapoptotic proteins (e.g., Bcl-xL, and Mcl-1) [20, 21] and proliferation regulatory proteins (e.g., cyclin D1, Myc, and survivin) [22–24].